LT - Nauji antikūnio-superantigeno konjugatai, jų gavimo būdas, ląstelės-taikinio lizavimo būdas ir konjugatų panaudojimas farmacinėse kompozicijose
EN - NEW ANTIBODY-SUPERANTIGEN CONJUGATES, PROCESS FOR PREPARING THEREOF, PROCESS FOR TARGET CELL LYSIS AND USE OF CONJUGATES IN PHARMACEUTICAL COMPOSITIONS
Legal status
Patent lapsed (non-payment of fees)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL.: (2006.01) |
A61K 39/395
C07C 217/00
C07C 271/00
C07D 209/00
|
Patent
| (11) |
Number of the document |
3909 |
| (13) |
Kind of document |
B |
| (21) |
Application number |
IP1632 |
| (22) |
Date of filing the application |
1993-12-20 |
| (41) |
Date of publication of the application |
1995-07-25 |
| (45) |
Date of publication of patent |
1996-04-25 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
9002479 |
1990-07-20
|
SE |
|
9002484 |
1990-07-20
|
SE |
|
PCT/SE91/00496 |
1991-07-16
|
WO |
Applicant
| (71) |
KABI PHARMACIA AB,
Rapsgatan 7, S-751 82 Uppsala,
SE
|
Inventors
| (72) |
Terje KALLAND, SE
Gunnar HEDLUND, SE
Mikael DOHLSTEN, SE
Peter LANDO, SE
Eva AKERBLOM, SE
|
Grantee
| (73) |
Active Biotech AB,
P.O. Box 724, SE-220 07 Lund,
SE
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
| (54) |
NEW ANTIBODY-SUPERANTIGEN CONJUGATES, PROCESS FOR PREPARING THEREOF, PROCESS FOR TARGET CELL LYSIS AND USE OF CONJUGATES IN PHARMACEUTICAL COMPOSITIONS
|
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2006-11-28 |
14 |
1000.00
LTL
|
Legal status
|
Patent lapsed (non-payment of fees)
|
|
|
Invalidation date |
2007-12-20 |
